Global Transcatheter Mitral valve Replacement Market, By Product (mechanical valve and Bioprosthetic tissue valve), By Diagnostic test (lateral flow assay, PCR assay, latex Agglutination tests),By End-user (hospital, clinics and others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI469821 | Publish Date: July 2021 | No. of Pages: 192

Global Transcatheter Mitral Valve Replacement Market Overview

Between the left atrium and the left ventricle is the mitral valve. Mitral valve disorder occurs when the valve fails to operate correctly, resulting in abnormal blood flow. Mitral valve prolapse and regurgitation are two diseases caused by this abnormal blood flow. Transcatheter mitral valve replacement (TMVR) has emerged as an alternative treatment choice for serious mitral regurgitation in patients who are unable or unwilling to undergo surgery. With a low rate of residual mitral regurgitation and low transvalvular gradients, transcatheter mitral valve replacement produces excellent hemodynamic performance. As the field of transcatheter mitral valve replacement (TMVR) advances and grows, using the heart team approach to define and individualise the most suitable care for each patient will become a vital part of assessing patients with mitral valve disease. The Transcatheter Mitral valve replacement market accounted for US$ 0.92  billion in 2020 and is estimated to be US$ 14.5 billion by 2030 and is anticipated to register a CAGR of 31.4%.

Impact of Covid-19 pandemic on market

The COVID 19 pandemic has put a strain on healthcare systems and intensive care unit  capability, causing many procedures to be halted, including transcatheter mitral  valve replacement .

Global Transcatheter Mitral Valve Replacement Market Dynamics

 

Growth in business operations by emerging and small sized players

The demand is growing due to an increase in the geriatric population and an increase in mitral valve disorders. Other factors that contribute to market growth include technological advances and the launch of novel mitral valves. Percutaneous transcatheter mitral valve replacement is a practical and relatively safe choice for patients with mitral regurgitation. These approaches are proving to be useful for patients who are at risk of developing mitral valve disease in terms of protection and effectiveness. The increasing demand for this technique is boosting the global transcatheter mitral valve implantation market's growth prospects over the forecast period.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Transcatheter Mitral Valve Replacement Market Segmentation

                                                       

The transcatheter mitral valve replacement market is segmented based on product, application, end-use, and region.

On the basis of product, the Transcatheter mitral valve replacement market is segmented into mechanical valves and Bioprosthetic tissue valves. Based on application, the target market is segmented into mitral valve stenosis, mitral valve prolapse and mitral valve regurgitation. On the basis of end-use, the target market is segmented into hospitals, ambulatory surgical centers, diagnostic centers and others.

Regional Insights:

                                                           

On region the Transcatheter mitral valve replacement market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The global transcatheter mitral valve repair and replacement market was dominated by North America. This is due to improved healthcare facilities as well as increased understanding of mitral valve diseases and the advantages of mitral valve repair and replacement.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2030

Market Segmentation

By product- mechanical valves and Bioprosthetic tissue valves

By Application– mitral valve stenosis, mitral valve prolapse and mitral valve Regurgitation

By End-use– hospital, ambulatory surgical centers, diagnostic centers and others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the Transcatheter mitral valve replacement market report based on product, application, end-use and region.

 

                                                                

Transcatheter Mitral valve replacement Market, By Region:

      • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Transcatheter Mitral Valve Replacement Market Key Players

The key players operating in the Transcatheter Mitral valve replacement market includes Abbott Laboratories, Biotronik Pvt Ltd, Colibri Heart Valve, LLC, Edward Lifesciences, HLT Medical, LivaNova Plc, Medtronic Plc, Neovasc Inc., NeoChord, Venus Medtech, Transcatheter Technologies GmbH, MValve Technologies and Mardil Medical.

Global Transcatheter Mitral Valve Replacement Market Company Profile

  • Abbott laboratories
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Biotronik Pvt Ltd
  • Colibri Heart Valve
  • Edward Lifesciences
  • HLT Medical
  • LivaNova Plc
  • Medtronic Plc
  • Neovasc Inc.
  • NeoChord
  • Venus Medtech
  • Transcatheter Technologies GmbH
  • MValve Technologies
  • Mardil Medical.

“*” marked represents similar segmentation in other categories in the respective section

Global Transcatheter Mitral Valve Replacement Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Transcatheter Mitral valve replacement Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Product
      • Market Snippet, By Application
      • Market Snippet, By End-User
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Transcatheter Mitral valve replacement Market, By Product,  2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Mechanical valves
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Bioprosthetic tissue valves
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Transcatheter Mitral valve replacement Market, By Application, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Mitral valve stenosis
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Mitral valve prolapse
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Mitral valve regurgitation
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Transcatheter Mitral valve replacement Market, By End-use, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Hospitals
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Ambulatory surgical centers
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Diagnostic centers
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global Transcatheter Mitral valve replacement Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  10. Company Profiles
  • Abbott laboratories
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Biotronik Pvt Ltd
  • Colibri Heart Valve
  • LLC
  • Edward Lifesciences
  • HLT Medical
  • LivaNova Plc
  • Medtronic Plc
  • Neovasc Inc.
  • NeoChord
  • Venus Medtech
  • Transcatheter Technologies GmbH
  • MValve Technologies
  • Mardil Medical.

The Last Word

    • Future Impact
    • About Us
    • Contact

FAQs

The Transcatheter mitral valve replacement market is segmented based on product, application, end-use, and region.

The demand is growing due to an increase in the geriatric population and an increase in mitral valve disorders. Other factors that contribute to market growth include technological advances and the launch of novel mitral valves.

The global transcatheter mitral valve repair and replacement market was dominated by North America. This is due to improved healthcare facilities as well as increased understanding of mitral valve diseases and the advantages of mitral valve repair and replacement.

Companies are continuously rising the contributions for market growth including technological advances and the launch of novel mitral valves.